EP Patent

EP2406389A1 — Methods and compositions for cell-proliferation-related disorders

Assigned to Agios Pharmaceuticals Inc · Expires 2012-01-18 · 14y expired

What this patent protects

Methods of treating and evaluating subjects having neoactive mutants are described herein.

USPTO Abstract

Methods of treating and evaluating subjects having neoactive mutants are described herein.

Drugs covered by this patent

Patent Metadata

Patent number
EP2406389A1
Jurisdiction
EP
Classification
—
Expires
2012-01-18
Drug substance claim
No
Drug product claim
No
Assignee
Agios Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.